Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
483-10-3COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1OBLGXFZZNTVWLAY-DKJBZYCGSA-N186 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
184.96 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];171.55 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];182.23 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];181.99 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.
Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS.
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS.
BeschreibungThis alkaloid has been isolated by Hoffmann from the bark of Rauwolfia serpentina. It forms colourless crystals from Me2CO and has [α]20D - 82° (c 0.5, pyridine).
Wird geladen…
483-10-3DTXSID401317915CHEBI:92122